Life Science & Biotech Companies in London

ML-driven antibody discovery platform for solid tumour therapeutics

LabGenius Therapeutics is a company developing next-generation therapeutic antibodies using its closed-loop machine learning platform. The platform integrates AI, robotic automation and high-throughput experimentation to co-optimise multispecific antibodies across potency, selectivity and manufacturability…

Clinical-stage biopharma targeting cancer immunotherapy and obesity

Poolbeg Pharma is a clinical-stage biopharmaceutical company developing small molecule therapies for high unmet medical needs. Its lead programme, POLB 001, is a p38 MAP kinase inhibitor in clinical trials for prevention of cytokine release syndrome associated with CAR-T and bispecific antibody cancer immunotherapies.…

Nanotechnology drug delivery platform for precision medicines

Nanomerics is a UK speciality pharmaceutical company developing precision medicines using its proprietary technology, a polymer nanotechnology platform that improves the bioavailability and targeting of water-insoluble drugs and peptides. The technology enables delivery via nasal, ocular, oral, and blood-brain barrier…

Breast milk microbiome biotech developing infant health solutions

BoobyBiome Ltd is a biotechnology company developing products to give formula-fed and high-risk infants access to the beneficial microbiome of breast milk. Its platform is built on the world's first high-resolution breast milk microbiome database and a proprietary biobank of strains from hundreds of donor samples. Its…

AI-powered immune profiling platform for precision medicine

IMU Biosciences is a biotechnology company coupling high-resolution, systems-level immune profiling with proprietary AI analytics to build a detailed atlas of the human immune system across health and disease. Its platform can identify and analyse over 2,000 immune cell subsets from blood samples, generating…

Synthetic DNA, gene synthesis and NGS reagents for life science research

Twist Bioscience is a synthetic biology company offering a broad portfolio of DNA-based products and services for research, diagnostics, and therapeutic development. Its silicon-based DNA synthesis platform enables high-throughput production of synthetic genes, oligo pools, NGS target enrichment panels, and antibody…

Full-service CRO specialising in oncology and early-phase trials

Pivotal CRO is a full-service contract research organisation providing end-to-end clinical development support across all trial phases, from first-in-human to Phase III. The company offers clinical operations, regulatory affairs, data management, biostatistics, medical monitoring, pharmacovigilance, and patient…

Acoustic levitation systems for contact-free laboratory automation

AcoustoFab is a developer of acoustic levitation instruments and software-controlled robotic systems for contact-free handling of laboratory samples. Using phased ultrasound arrays, the company manipulates droplets, particles and powders without conventional pipettes or grippers. Its technology supports automated…

Electrochemical water contaminant sensors and mapping software

AquAffirm is a UK environmental sensing company developing portable digital tests for water contaminants and associated analytical software. Its smartphone-connected electrochemical sensors target substances including arsenic, salinity, chlorine, antibiotics and perfluorinated chemicals. The AquaFORM platform supports…

AI-enabled genomic and clinical data analysis for research

SökerData is a health data technology company developing AI-enabled tools for analysis of genomic and clinical datasets from underrepresented populations. Its platform helps life-science researchers explore biomarker associations across demographic groups and identify representation gaps in health data used for drug…

RBC derived nanoparticles for RNA delivery to brain and immune cells

Crane Biosciences is a biotechnology company developing a non-immunogenic RNA delivery platform based on nanoparticles derived from red blood cell membranes. By using the body's own cellular architecture as a delivery vehicle, the platform achieves substantially higher in vivo delivery efficiency to target tissues…

Ultrasensitive proteomics and biomarker assay development CRO

Altheome is a contract research organisation specialising in protein biomarkers and ultrasensitive proteomics for pharmaceutical, biotechnology and academic studies. Its services include custom assay development, biomarker discovery and validation, protocol optimisation and pharmacokinetic or pharmacodynamic analysis.…

Software standardising experimental protocols for reproducibility and lab automation

Briefly Bio is a software company that helps scientists record experimental protocols in a clear, structured and consistent format. Its platform uses AI to identify gaps and errors in protocol descriptions and to validate and adapt protocols for specific lab automation systems. The company aims to improve experimental…

AstraZeneca's rare disease arm targeting the complement cascade

Alexion, AstraZeneca Rare Disease is the rare disease group within AstraZeneca, formed following the 2021 acquisition of Alexion Pharmaceuticals. With nearly 30 years of rare disease heritage, the division focuses on novel molecules targeting the complement cascade across haematology, nephrology, neurology, metabolic…

Semiconductor biosensors for blood-based cancer biomarker detection

ExoNostic is a diagnostic technology company developing semiconductor biosensors for cancer biomarker detection. Its investigational lab-on-a-chip platform is designed to identify molecular signatures in small blood samples, combining sensor-based measurements with computational interpretation. An Innovate UK-funded…

Serviced biotechnology laboratories and startup incubator

OpenCell is a London life sciences incubator and laboratory operator providing modular, serviced laboratory space for biotechnology startups. Its BioHotel facilities offer configurable BSL2+ laboratory units alongside shared scientific infrastructure, equipment access, storage, consumables management and operational…

UK learned society for pharmacology and medicines research

The British Pharmacological Society (BPS) is a UK membership charity dedicated to promoting and advancing all disciplines of pharmacology in the discovery, development, and use of medicines. It supports a global community of over 4,500 members across more than 60 countries through scientific publishing, conferences,…

Asymmetric biomaterial skin substitutes for acute and chronic wounds

Janus Biosciences is a biotech developing novel biomaterial skin substitutes for the treatment of acute and chronic wounds. The platform is based on asymmetric Janus material architectures, in which opposing faces of the scaffold present distinct physicochemical properties to simultaneously support wound bed healing…

Graphene nanocomposites and biomaterials for regenerative medicine research

NanoRegMed is a London biotechnology company developing graphene-based polymers and nanocomposites for regenerative medicine and industrial applications. Its Hastalex and BioHastalex materials have tunable properties for potential tissue repair and implant applications. The company also supplies reduced and…

Clinical-stage peptide therapeutics for autoimmune and infectious disease

ImmuPharma is a clinical-stage biopharmaceutical company developing peptide-based therapeutics and precision diagnostics for autoimmune disease, infectious disease and metabolic disorders. Its lead candidate, a first-in-class immunormalizer for lupus, has completed a Phase III pivotal trial, aiming to restore normal…